Litigation Details for AstraZeneca AB v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)
✉ Email this page to a colleague
AstraZeneca AB v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-06-03 |
| Court | District Court, N.D. West Virginia | Date Terminated | 2017-03-10 |
| Cause | 35:145 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
| Jury Demand | None | Referred To | |
| Patents | 6,395,767; 7,951,400; 8,628,799; RE44,186 | ||
| Link to Docket | External link to docket | ||
Details for AstraZeneca AB v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-06-03 | 1 | The RE’ 186 patent is a reissue of U.S. Patent No. 6,395,767 (“the ‘767 patent”), which issued on…RE44,186 (“the RE’186 patent”) and U.S. Patent No. 7,951,400 (“the ‘400 patent”). 3. …expiration of the RE’186 patent and U.S. Patent No. 8,628,799 (“the ‘799 patent”). …Attachments: # 1 Exhibit A copy of Patent # US RE44,186E, # 2 Exhibit B copy of Patent # US 7,951,400 B2, # 3 Exhibit… This is an action for patent infringement arising under the patent laws of the United States, | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
